Chinese medicine formulas for nonalcoholic fatty liver disease: Overview of systematic reviews

Table 3 Risk of bias of the included systematic reviews evaluated by risk of bias in the systematic review

Ref.	Phase 1	Phase 2				Phase 3
	Relevance	Study eligibility criteria	Identification and selection of studies	Data collection and study appraisal	Synthesis and findings	Risk of bias in the review
Cai et al[9], 2019	Yes	Low risk	High risk	Low risk	Low risk	High risk
Shi et al[8], 2012	Yes	Low risk	High risk	High risk	High risk	High risk
He et al[16], 2010	Yes	Low risk	High risk	High risk	High risk	High risk
Li et al[17], 2011	Yes	High risk	High risk	High risk	High risk	High risk
Li et al[18], 2014	Yes	High risk	High risk	High risk	Not clear	High risk
Yang et al[19], 2019	Yes	Low risk	High risk	High risk	Low risk	High risk
Zhang et al[20], 2014	Yes	Low risk	High risk	High risk	High risk	High risk